Lantern Pharma Inc. (LTRN)
NASDAQ: LTRN
· Real-Time Price · USD
3.12
-0.06 (-1.89%)
At close: Jun 23, 2025, 3:59 PM
3.13
0.32%
After-hours: Jun 23, 2025, 04:12 PM EDT
-1.89% (1D)
| Bid | 3 |
| Market Cap | 33.65M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -19.88M |
| EPS (ttm) | -1.84 |
| PE Ratio (ttm) | -1.7 |
| Forward PE | -2.02 |
| Analyst | Buy |
| Ask | 3.13 |
| Volume | 37,764 |
| Avg. Volume (20D) | 53,032 |
| Open | 3.11 |
| Previous Close | 3.18 |
| Day's Range | 3.06 - 3.16 |
| 52-Week Range | 2.55 - 6.12 |
| Beta | 1.54 |
About LTRN
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol LTRN
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for LTRN stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts3 weeks ago
+9.06%
LTRN stock has given up its prior gain. Lantern Ph...
Unlock content with
Pro Subscription
3 weeks ago
+9.06%
Lantern Pharma shares are trading higher after the company announced preclinical data for LP-184.
